Yeh, W. Z. Et Al. 2021. Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis. NEUROLOGY , vol.96, no.24 .

Yeh, W. Z., Widyastuti, P. A., Van der Walt, A., Stankovich, J., Havrdova, E., Horakova, D., ... Vodehnalova, K.(2021). Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis. NEUROLOGY , vol.96, no.24.

Yeh, Wei Et Al. "Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis," NEUROLOGY , vol.96, no.24, 2021

Yeh, Wei Z. Et Al. "Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis." NEUROLOGY , vol.96, no.24, 2021

Yeh, W. Z. Et Al. (2021) . "Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis." NEUROLOGY , vol.96, no.24.

@article{article, author={Wei Zhen Yeh Et Al. }, title={Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis}, journal={NEUROLOGY}, year=2021}